Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07488195 · ClinicalTrials.gov registry record · NA
A Study Of Phototherapy In Patients With Dementia To Improve BPSD
A NA study, sponsored by Mayo Clinic.
- Not yet
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT07488195: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT07488195 is a NA study that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07488195, a NA study, has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this research is to determine whether the use of phototherapy can help reduce behavioral and psychological symptoms, including agitation in people with dementia.
Primary Outcome
Feasibility will be defined as the percentage of eligible patients who choose to enroll in the study out of total patients approached.
Interventions
- OTHER Phototherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What is known before NCT07488195 opens enrollment
NCT07488195 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Phototherapy is the first listed.
NCT07488195 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07488195 about?
NCT07488195 is a clinical study titled "A Study Of Phototherapy In Patients With Dementia To Improve BPSD". The purpose of this research is to determine whether the use of phototherapy can help reduce behavioral and psychological symptoms, including agitation in people with dementia.
What is the current status of trial NCT07488195?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2026-06-01. Estimated completion is 2026-12-31.
What interventions are being tested in trial NCT07488195?
The interventions under investigation include: Phototherapy (OTHER).
Who is sponsoring clinical trial NCT07488195?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07488195's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI